CLBT
Cellebrite DI Ltd.NASDAQTechnology$14.00+0.86%OpenMarket Cap: $3.49B
As of 2026-04-06
Valuation
P/E (TTM)
44.58
PEG
0.35
P/B
7.68
P/S
7.34
EV/EBITDA
40.53
DCF Value
$5.75
FCF Yield
4.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
84.2%
Operating Margin
14.0%
Net Margin
16.5%
ROE
18.4%
ROA
10.6%
ROIC
10.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $128.8M | 84.7% | $20.8M | $21.3M | $0.08 | — |
| FY 2025 | $475.7M | 84.2% | $66.5M | $78.3M | $0.31 | — |
| Q3 2025 | $126.0M | 83.9% | $19.0M | $20.2M | $0.08 | — |
| Q2 2025 | $113.3M | 84.4% | $14.4M | $19.5M | $0.08 | — |
| Q1 2025 | $107.5M | 83.7% | $12.3M | $17.4M | $0.07 | — |
| Q4 2024 | $109.0M | 83.8% | $15.7M | $19.3M | $0.08 | — |
| FY 2024 | $401.2M | 84.4% | $56.9M | $-283.0M | $-1.35 | — |
| Q3 2024 | $106.9M | 85.5% | $19.4M | $-207.1M | $-0.99 | — |
| Q2 2024 | $95.7M | 83.0% | $12.5M | $-23.8M | $-0.12 | — |
| Q1 2024 | $89.6M | 85.2% | $9.2M | $-71.4M | $-0.36 | — |
| Q4 2023 | $93.0M | 84.0% | $15.0M | $-14.6M | $-0.08 | — |
| FY 2023 | $325.1M | 83.6% | $33.2M | $-81.1M | $-0.43 | — |